DDrare: Database of Drug Development for Rare Diseases

Searched query = "Hirschsprung disease, entire colon type", "Hirschsprung disease, small intestine type", "Hirschsprung disease", "Hirschprung disease", "Hirschsprung disease associated entercolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Behavioral: anal dilation; Behavioral: colonic lavage; Behavioral: conservative treatment; Bifico; Butyrate; Butyrate enemas + routine management; Cefazolin; Citric acid; Device: SPY imaging; Erythromycin; Gold; High dose lactulose; Indocyanine Green; Indocyanine green; Kanamycin; Lactulose; Magnesium; Magnesium oxide; Metronidazole; Oral probiotic; Other: Nil per os; Other: routine management; Paraffin Oil; Paraffin oil; Picosulfate; Probiotics; Procedure: surgery treatment; Racol; Senna; Sodium Picosulfate, Magnesium Oxide and Citric Acid; Supplement nutritional supporting; VSL#3

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00630838 (ClinicalTrials.gov)	September 2006	28/2/2008	Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)	Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)	Hirschsprung Disease	Drug: VSL#3;Drug: Placebo	University of Michigan	NULL	Completed	1 Month	12 Months	All	62	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00630838
(ClinicalTrials.gov)

September 2006

28/2/2008

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

Hirschsprung Disease

Drug: VSL#3;Drug: Placebo

University of Michigan

NULL

Completed

1 Month

12 Months

All

Phase 2

United States